An artificial pancreas that can be implemented to diabetes patients and who releases insulin has been chosen better invention of the year in the United Kingdom.
An artificial pancreas can help manage insulin dose to diabetes.
The British Joan Taylor, Professor of Pharmacy at that university, is the inventor of that small device, which was prepared with the collaboration of the Renfrew Group International Medical Technology Company."This incredible device developed with Renfrew will not only eliminate the need to inject insulin manually, but will also ensure that exact doses are administered every time," Taylor said.
The invention received the award at the Gadget Show Live, a technology fair sponsored by a British television program.Scientists are expected to do the first clinical tests in 2016 and it is estimated that the National Health Service (NHS) of the United Kingdom will make the first implants in a decade.
"When controlling blood glucose levels so effectively, we should reduce related health problems," said the inventor.Taylor said that diabetes currently costs a million pounds (¤1.2 million) the time to public health and most of them are spent on treating complications.Michael Phillips, from Renfrew Group, said: "This simple device has the potential to benefit millions of lives."
The artificial pancreas must be surgically implanted in the body, where it is designed to release precise amounts of insulin to the blood flow.Every two weeks the device must be filled with insulin, they explain the inventors, which point out that the gadget will serve both patients with type 1 diabetes, dependent on insulin, and some patients with type 2 diabetes who also require injections.The "pancreas" is not electronic, it works with a polymer gel that automatically controls the release of insulin, which, according to experts, minimizes the risk of rejection by the patient.